Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA

European Journal of Immunology

Volumn 45, Issue 1, 2015, Pages 203-213

  Lande, Roberto ^a,b   Chamilos, Georgios ^c,d   Ganguly, Dipyaman ^c,e   Demaria, Olivier ^a   Frasca, Loredana ^a,b   Durr, Sophie ^a   Conrad, Curdin ^a   Schröder, Jens ^f   Gilliet, Michel ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CRETE   (Greece)

^e INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

Antimicrobial peptides; Plasmacytoid DC; Psoriasis; Skin; Toll like receptor

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DNA; ELAFIN; INTERFERON; LYSOZYME; PSORIASIN; TOLL LIKE RECEPTOR 9; BETA DEFENSIN; BETA-DEFENSIN 3, HUMAN; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; DEFB4A PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; DNA STRAND BREAKAGE; ELECTROSPRAY MASS SPECTROMETRY; ENDOCYTOSIS; ENZYME DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; IONIC STRENGTH; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSORIASIS; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LANGERHANS CELL; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN; T LYMPHOCYTE;

BETA-DEFENSINS; CATHELICIDINS; DENDRITIC CELLS; DNA; GENE EXPRESSION REGULATION; HUMANS; LANGERHANS CELLS; MURAMIDASE; PSORIASIS; SELF TOLERANCE; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 84920991973     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344277     Document Type: Article

References (48)

1. Lowes, M. A., Bowcock, A. M. and Krueger, J. G., Pathogenesis and therapy of psoriasis. Nature 2007. 445: 866-873.
2. Nestle, F. O., Kaplan, D. H. and Barker, J., Psoriasis. N. Engl. J. Med. 2009. 361: 496-509.
3. Griffiths, C. E. and Barker, J. N., Pathogenesis and clinical features of psoriasis. Lancet 2007. 370: 263-271.
4. Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S. L., Nussbaum, R., Novitskaya, I. et al., Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 2005. 102: 19057-19062.
5. Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G. et al., Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 2005. 202: 135-143.
6. Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L. and Nickoloff, B. J., The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest Dermatol. 1993. 101: 701-705.
7. Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P. et al., Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 2008. 128: 1207-1211.
8. Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suarez-Farinas, M., Fuentes-Duculan, J., Novitskaya, I. et al., Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007. 204: 3183-3194.
9. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648-651.
10. Harder, J. and Schroder, J. M., Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 2005. 77: 476-486.
11. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L. et al., Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002. 347: 1151-1160.
12. Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Liden, S., Wigzell, H. and Gudmundsson, G. H., The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 1997. 272: 15258-15263.
13. Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature 2002. 415: 389-395.
14. Zanetti, M., Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004. 75: 39-48.
15. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V. et al., Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001. 414: 454-457.
16. Harder, J., Bartels, J., Christophers, E. and Schroder, J. M., A peptide antibiotic from human skin. Nature 1997. 387: 861.
17. Harder, J., Bartels, J., Christophers, E. and Schroder, J. M., Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001. 276: 5707-5713.
18. Madsen, P., Rasmussen, H. H., Leffers, H., Honore, B., Dejgaard, K., Olsen, E., Kiil, J. et al., Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 1991. 97: 701-712.
19. Eckert, R. L., Broome, A. M., Ruse, M., Robinson, N., Ryan, D. and Lee, K., S100 proteins in the epidermis. J. Invest. Dermatol. 2004. 123: 23-33.
20. Henseler, T. and Christophers, E., Disease concomitance in psoriasis. J. Am. Acad. Dermatol. 1995. 32: 982-986.
21. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y. H., Homey, B., Cao, W. et al., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007. 449: 564-569.
22. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B. et al., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009. 206: 1983-1994.
23. Gregorio, J., Meller, S., Conrad, C., Di Nardo, A., Homey, B., Lauerma, A., Arai, N. et al., Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 2010. 207: 2921-2930.
24. Chamilos, G., Gregorio, J., Meller, S., Lande, R., Kontoyiannis, D. P., Modlin, R. L. and Gilliet, M., Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 2012. 120: 3699-3707.
25. Papini, M., Simonetti, S., Franceschini, S., Scaringi, L. and Binazzi, M., Lysozyme distribution in healthy human skin. Arch. Dermatol. Res. 1982. 272: 167-170.
26. Wiedow, O., Schroeder, J. M., Gregory, H., Young, J. A. and Christophers, E., Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 1990. 265: 14791-14795.
27. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boquniewicz, M., Ganz, T., Gallo R. L. et al., Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002. 347: 1151-1160.
28. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S. et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 2011. 3: 1-11.
29. Fulton, C., Anderson, G. M., Zasloff, M., Bull, R. and Quinn, A. G., Expression of natural peptide antibiotics in human skin. Lancet 1997. 350: 1750-1751.
30. Lande, R. and Gilliet, M., Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann. N. Y. Acad. Sci. 2010. 1183: 89-103.
31. Levy, O., Antibiotic proteins of polymorphonuclear leukocytes. Eur. J. Haematol. 1996. 56: 263-277.
32. Sorensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F. and Borregaard, N., The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997. 90: 2796-2803.
33. Singh, P. K., Tack, B. F., McCray, P. B., Jr. and Welsh, M. J., Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. 279: L799-L805.
34. Yan, H. and Hancock, R. E., Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 2001. 45: 1558-1560.
35. Bloomfield, V. A., DNA condensation. Curr. Opin. Struct. Biol. 1996. 6: 334-341.
36. Welch, J., Svensson, K., Kucharzewska, P. and Belting, M., Heparan sulfate proteoglycan-mediated polyamine uptake. Methods Mol. Biol. 2011. 720: 327-38.
37. Sandgren, S., Wittrup, A., Cheng, F., Jönsson, M., Eklund, E., Busch, S. and Belting, M., The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 2004. 279(17): 17951-6.
38. Niidome, T., Wakamatsu, M., Wada, A., Hirayama, T. and Aoyagi, H., Required structure of cationic peptide for oligonucleotide-binding and -delivering into cells. J. Pept. Sci. 2000. 6: 271-279.
39. Ciornei CD, Sigurdardóttir T, Schmidtchen A, and Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother. 2005. 49: 2845-2850.
40. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K. and Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 2004. 21: 241-254.
41. Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., Fouser, L. A. et al., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006. 203: 2271-2279.
42. Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suarez Farinas, M., Fuentes-Duculan, J., Novitskaya, I. et al., Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007. 204: 3183-3194.
43. Krueger, J. G., Fretzin, S., Suarez-Farinas, M., Haslett, P. A., Phipps, K. M., Cameron, G. S., McColm, J. et al., IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J. Allergy Clin. Immunol. 2012. 130: 145-154.
44. Hollox, E. J., Huffmeier, U., Zeeuwen, P. L., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P. C. et al., Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 2008. 40: 23-25.
45. Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, Fortugno P. et al., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 2009. 206: 249-58.
46. Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jadlowsky, J., Harding, C. V., Weinberg, A. et al., Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 2007. 104: 18631-18635.
47. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K. et al., Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002. 298: 1025-1029.
48. Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E. and Schröder, J. M., Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 2005. 1: 57-64.